Steris | Koszty Sprzedaży I Administracji



Selling And Administration Expenses Zmiana Data
3M USD 899M 163M 2024-12
Avanos Medical USD 79.6M 6.9M 2024-12
Baxter International USD 615M 16M 2024-12
Becton, Dickinson and Co. USD 1.32B 62M 2024-12
Boston Scientific USD 1.61B 50M 2024-12
CONMED USD 123.97M 33.04M 2024-12
Cooper Companies USD 387.9M 3.5M 2025-01
Dexcom USD 327.4M 21M 2024-12
Ecolab USD 1.05B 25.2M 2024-12
Edwards Lifesciences USD 491.9M 70.5M 2024-12
Fortive USD 559.1M 36.9M 2024-12
Getinge SEK 2.65B 452M 2024-12
Globus Medical USD 253.48M 12.74M 2024-12
Haemonetics USD 105.72M 686K 2024-12
Hologic USD 265M 15.8M 2024-12
Idexx Laboratories USD 251.24M 13.08M 2024-12
Insulet USD 261M 26.9M 2024-12
Integra LifeSciences USD 169.62M 5.48M 2024-12
Intuitive Surgical USD 612.6M 102M 2024-12
J&J USD 6.45B 975M 2024-12
Masimo USD 223.4M 38.6M 2024-12
Olympus JPY 125.07B 6B 2024-12
Owens Minor USD 493.07M 23.27M 2024-12
ResMed USD 241.61M 2.63M 2024-12
Steris USD 335.45M 9.36M 2024-12
Stryker USD 2.03B 229M 2024-12
Tandem Diabetes Care USD 105.84M 6.2M 2024-12
Teleflex USD 254.55M 7.3M 2024-12
Thermo Fisher Scientific USD 2.21B 114M 2024-12
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12



Steris Koszty Sprzedaży I Administracji - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.